Chugai OTC Stock Future Price Prediction

CHGCF -  USA Stock  

USD 27.57  0.00  0.00%

Chugai Pharmaceutical stock price prediction is an act of determining the future value of Chugai Pharmaceutical shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Chugai Pharmaceutical's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Chugai Pharmaceutical and does not consider all of the tangible or intangible factors available from Chugai Pharmaceutical's fundamental data. We analyze noise-free headlines and recent hype associated with Chugai Pharmaceutical, which may create opportunities for some arbitrage if properly timed.
Continue to Chugai Pharmaceutical Basic Forecasting Models to cross-verify your projections.
  
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Chugai Pharmaceutical based on different types of headlines from major news networks to social media. The Chugai stock price prediction module provides an analysis of price elasticity to changes in media outlook on Chugai Pharmaceutical over a specific investment horizon. Using Chugai Pharmaceutical hype-based prediction, you can estimate the value of Chugai Pharmaceutical from the perspective of Chugai Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Chugai Pharmaceutical. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Chugai Pharmaceutical to buy its stock at a price that has no basis in reality. In that case, they are not buying Chugai because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Chugai Pharmaceutical after-hype prediction price

    
  $ 27.57  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Chugai Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Chugai Pharmaceutical in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
22.6324.3430.33
Details
Naive
Forecast
LowNext ValueHigh
25.2026.9128.61
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
27.5727.5727.57
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Chugai Pharmaceutical. Your research has to be compared to or analyzed against Chugai Pharmaceutical's peers to derive any actionable benefits. When done correctly, Chugai Pharmaceutical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Chugai Pharmaceutical.

Chugai Pharmaceutical After-Hype Price Prediction Density Analysis

As far as predicting the price of Chugai Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Chugai Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Chugai Pharmaceutical, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Chugai Pharmaceutical Estimiated After-Hype Price Volatility

In the context of predicting Chugai Pharmaceutical's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Chugai Pharmaceutical's historical news coverage. Chugai Pharmaceutical's after-hype downside and upside margins for the prediction period are 25.86 and 29.28, respectively. We have considered Chugai Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 27.57
27.57
After-hype Price
29.28
Upside
Chugai Pharmaceutical is very steady asset. Analysis and calculation of next after-hype price of Chugai Pharmaceutical is based on 3 months time horizon.

Chugai Pharmaceutical OTC Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Chugai Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chugai Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Chugai Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
  0.36  1.71  0.00    0.62  6 Events / Month4 Events / MonthIn about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
27.5727.570.00 
0.00  

Chugai Pharmaceutical Hype Timeline

Chugai Pharmaceutical is currently traded for 27.57. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.62. Chugai forecasted not to react to the next headlinewith price going to stay at about the same level and average media hype impact volatility of about 0.0%. The immediate return on the next newsis forecasted to be very small whereas the daily expected return is currently at -0.36%. The volatility of relative hype elasticity to Chugai Pharmaceutical is about 100.1%. The volatility of related hype on Chugai Pharmaceutical is about 100.1% with expected price after next announcement by competition of 26.95. About 60.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.04. Some equities with similar Price to Book (P/B) outperform the market in the long run. Chugai Pharmaceutical next dividend is scheduled to be issued on the 29th of June 2022. The entity had a split on the 29th of June 2020. Assuming the 90 days horizon the next forecastedpress releasewill be in about 6 days.
Continue to Chugai Pharmaceutical Basic Forecasting Models to cross-verify your projections.

Chugai Pharmaceutical Related Hype Analysis

Having access to credible news sources related to Chugai Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Chugai Pharmaceutical's future price movements. Getting to know how Chugai Pharmaceutical rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Chugai Pharmaceutical may potentially react to the hype associated with one of its peers.

Chugai Pharmaceutical Additional Predictive Modules

Most predictive techniques to examine Chugai price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Chugai using various technical indicators. When you analyze Chugai charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Chugai Pharmaceutical Predictive Indicators

The successful prediction of Chugai Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Chugai Pharmaceutical, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Chugai Pharmaceutical based on analysis of Chugai Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Chugai Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Chugai Pharmaceutical's related companies.

Story Coverage note for Chugai Pharmaceutical

The number of cover stories for Chugai Pharmaceutical depends on current market conditions and Chugai Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Chugai Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Chugai Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Chugai Pharmaceutical Short Properties

Chugai Pharmaceutical's future price predictability will typically decrease when Chugai Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Chugai Pharmaceutical often depends not only on the future outlook of the potential Chugai Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Chugai Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
Trailing Annual Dividend Rate60.00
Float Shares636.05M
Average Daily Volume Last 10 Day1.07k
Average Daily Volume In Three Month838
Trailing Annual Dividend Yield217.63%
Continue to Chugai Pharmaceutical Basic Forecasting Models to cross-verify your projections. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Chugai OTC Stock analysis

When running Chugai Pharmaceutical price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Is Chugai Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chugai Pharmaceutical. If investors know Chugai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chugai Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chugai Pharmaceutical is measured differently than its book value, which is the value of Chugai that is recorded on the company's balance sheet. Investors also form their own opinion of Chugai Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Chugai Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chugai Pharmaceutical's market value can be influenced by many factors that don't directly affect Chugai Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chugai Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Chugai Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chugai Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.